outcomes can be inconsistent and unpredictable. While extensive research has explored the mechanisms
Khamidullina, Zemfira,
Avzaletdinova, Diana,
Gareeva, Diana,
Morugova, Tatyana,
Lakman, Irina,
Kopp, Kristen,
Fiedler, Lukas,
Motloch, Lukas J.,
Zagidullin, Naufal (2024) for adverse COVID-19
outcomes. The goal of study was to assess the characteristics and
outcomes strides in combating this devastating condition, ultimately improving patient
outcomes and quality of life
biomarkers and therapeutic interventions, holding the promise of markedly improved patient
outcomes and intervention are paramount to mitigating risks and improving
outcomes. By understanding these complex